FDA Inspection 1147144 — Manhattan Drug Co. Inc
The FDA completed an inspection of Manhattan Drug Co. Inc on July 22, 2021 in Hillside, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 22, 2021
- Fiscal Year
- 2021
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Hillside, NJ (United States)